Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma

Ming Jin,1,* Zhi-qing Jiang,2,* Jia-hui Qin,3,* Hui-xia Qin,4,* Kai-wen Jiang,3,* Hou-xiang Ya,3 Jing Gu,3 Mo-rui Gui,5 Yao-hua Li,3 Long-kuan Xu,6 Hai-xiao Fu,6 Xu-hua Xiao,7 Shu-qun Li3 1Department of Vascular Intervention, Affiliated Hospital of Guilin Medi...

Full description

Bibliographic Details

Published in:	Journal of Hepatocellular Carcinoma
Main Authors:	Jin M, Jiang ZQ, Qin JH, Qin HX, Jiang KW, Ya HX, Gu J, Gui MR, Li YH, Xu LK, Fu HX, Xiao XH, Li SQ
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-11-01
Subjects:	unresectable hepatocellular carcinoma lenvatinib transarterial chemoembolization pd-1 inhibitor combination therapy propensity score matching.
Online Access:	https://www.dovepress.com/efficacy-and-safety-of-lenvatinib-plus-programmed-death-1-inhibitors-w-peer-reviewed-fulltext-article-JHC